Nalaganje...
Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening
OBJECTIVES: The Prostate Cancer Prevention Trial (PCPT) prostate cancer risk calculator was developed to aid physicians in counseling men for consideration of prostate biopsy based on prostate-specific antigen (PSA) and other clinical risk factors. This study investigated the role of body mass index...
Shranjeno v:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2010
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2975830/ https://ncbi.nlm.nih.gov/pubmed/20739049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urology.2010.04.060 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|